Migraine medicines in the emergency department
Treatments studied
Part of Brain & nervous system clinical trials.
This trial tests whether a new class of migraine medicines, called gepants, can relieve migraine pain quickly when given in the emergency department. If you're having a migraine and haven't taken pain medication recently, you might be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old and able to understand and agree to the study.
- You must be in the emergency department with a migraine headache that started more than 48 hours after your last headache.
- You must be willing to answer a few short phone calls after you leave the hospital.
- You must be able to speak English or Spanish.
- You cannot have taken any migraine or pain medication within the last hour before the study drug is given.
- You cannot have used certain migraine drugs (CGRP-targeting medicines) in the past, or have serious heart, liver, kidney, or blood vessel problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
This study tests how well a new acute migraine medicine, zavegepant, works and is tolerated in people who are already taking a CGRP-targeting preventive medication. It may help you find an effective treatment when you get a migraine attack.
This study tests a nasal spray called zavegepant to see how well it treats migraine attacks quickly. It may help people who have frequent migraines and need a fast-acting treatment.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.
This study tests an add-on migraine medicine (eptinezumab) given in the emergency room to quickly relieve a migraine attack, in addition to the usual care. It aims to see if this approach reduces pain and prevents the migraine from coming back.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.